Tobacco and Public Health - TCSC Indonesia

162
BEHAVIORAL PHARMACOLOGY OF NICOTINE REINFORCEMENT
Chandler, C. J. and Stolerman, I. P. (1997). Discriminative stimulus properties of the nicotinic
agonist cytisine. Psychopharmacol, 129, 257–64.
Clarke, P.B.S.(1990). Dopaminergic mechanisms in the locomotor stimulant effects of nicotine.
Biochem Pharmacol, 40, 1427–32.
Clarke, P. B. S. and Kumar, R. (1983). The effect of nicotine on locomotor activity in non-tolerant
and tolerant rats. Br J Pharmacol, 78, 329–37.
Corrigall, W. A. and Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a
limited-access schedule. Psychopharmacol, 99, 473–8.
Corrigall, W. A. and Coen, K. M. (1994). Dopamine mechanisms play at best a small role in the
nicotine discriminative stimulus.Pharmacol Biochem Behav, 48, 817–20.
Corrigall,W.A., Coen, K. M., and Adamson, K. L. (1994). Self-administered nicotine activates the
mesolimbic dopamine system through the ventral tegmental area. Brain Res, 653, 278–84.
DiChiara, G. (2000). Role of dopamine in the behavioral actions of nicotine related to addiction.
Eur J Pharmacol, 393, 295–314.
Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., et al. (1999).
Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.
Psychopharmacol, 147, 135–42.
Donny, E. C., Caggiula, A. R., Rowell, P. P., Gharib, M. A., Maldovan, V., Booth, S., et al. (2000).
Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor
binding. Psychopharmacol, 151, 392–405.
Duka, T., Seiss, E., and Tasker, R. (2002). The effects of extrinsic context on nicotine discrimination.
Behav Pharmacol, 13, 39–47.
Dwoskin, L. P., Crooks, P. A., Teng, L., Green, T. A., and Bardo, M. T. (1999). Acute and chronic effects
of nornicotine on locomotor activity in rats: altered response to nicotine. Psychopharmacol, 145,
442–51.
Dwoskin, L. P. and Crooks, P. A. (2001). Competitive neuronal nicotinic receptor antagonists: a new
direction for drug discovery. J Pharmacol Exp Ther, 298, 345–402.
Ericson, M., Olausson, P., Engel, J. A., and Soderpalm, B. (2000). Nicotine induces disinhibitory
behavior in the rat after subchronic peripheral nicotine acetylcholine receptor blockade.
Eur J Pharmacol, 397, 103–11.
Ferrari, R., Le Novere, N., Picciotto, M. R., Changeux, J. P., and Zoli, M. (2002). Acute and long-term
changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections.
Eur J Neurosci, 15, 1810–18.
Fischman, M. W. and Foltin, R. W. (1991). Utility of subjective effects measurements in assessing
abuse liability of drug in humans. Br J Addict, 86, 1563–70.
Fudala, P. J., Teoh, K. W., and Iwamoto, E. T. (1985). Pharmacologic characterization of nicotine-induced
conditioned place preference. Pharmacol Biochem Behav, 22, 237–41.
Garrett, B. E. and Griffiths, R. R. (2001). Intravenous nicotine and caffeine: subjective and
physiological effects in cocaine abusers. J Pharmacol Exp Ther, 296, 486–94.
Goldberg, S. R. and Henningfield, J. E. (1998). Reinforcing effects of nicotine in humans and
experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol
Biochem Behav, 30, 227–34.
Goldberg, S. R., Spealman, R. D., and Goldberg, D. M. (1981). Persistent behavior at high rates
maintained by intravenous self-administration of nicotine. Science, 214, 573–5.
Goldberg, S. R., Spealman, R. D., Risner, M. E., and Henningfield, J. E. (1983). Control of behavior
by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav, 19,
1011–20.